The Future of Obesity Drugs

It's a more desirable product because you don't have to like shoot yourself with a needle. So of course, they're going to charge as much as they can. Once once both companies are producing at scale and there's a surplus of this stuff, then the prices could come down. But until then, why would they? Yeah, by the way, guys, I'm not into Pfizer on this trade. It's Lily and Nova. Those are my those are my trades on this.